Microangiopatía trombótica en el seno de una prostatitis aguda
Open Access
- 24 April 2024
- journal article
- research article
- Published by Sociedad Espanola de Medicina Interna (SEMI) in Revista Española de Casos Clínicos en Medicina Interna
- Vol. 9 (1) , 23-25
Abstract
RECCMI es una revista de casos clínicos en Medicina Interna que utiliza el software Open Journal Systems 3.1. We present the case of a 46-year-old man who was admitted to the hospital for an episode of acute prostatitis and who, during hospitalization, presented a progressive and severe deterioration of renal function accompanied by hemolytic anemia and severe thrombocytopenia. After an etiological study, a diagnosis of thrombotic microangiopathy was reached. Treatment with eculizumab and plasmapheresis was started with a good response. Presentamos el caso de un varón de 46 años que ingresó por un episodio de prostatitis aguda y durante la hospitalización presentó un deterioro progresivo y severo de la función renal acompañado de anemia hemolítica y trombocitopenia severa. Tras estudio etiológico se llegó al diagnóstico de una microangiopatía trombótica. Se inició tratamiento con eculizumab y plasmaféresis con buena respuesta.Keywords
This publication has 8 references indexed in Scilit:
- Thrombotic Microangiopathy Syndromes—Common Ground and Distinct FrontiersAdvances in Chronic Kidney Disease, 2022
- Long-term Kidney Outcomes in Patients With Acquired Thrombotic Thrombocytopenic PurpuraKidney International Reports, 2017
- HUS and atypical HUSBlood, 2017
- Atypical aHUS: State of the artMolecular Immunology, 2015
- Successful treatment of DEAP-HUS with eculizumabPediatric Nephrology, 2013
- Genetics and Outcome of Atypical Hemolytic Uremic SyndromeClinical Journal of the American Society of Nephrology, 2013
- Thrombotic MicroangiopathiesNew England Journal of Medicine, 2002
- Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpuraKidney International, 2001